Having trouble accessing articles? Reset your cache.

PDL receives royalty payment from Genentech

PDL BioPharma Inc. (NASDAQ:PDLI) reported that Genentech Inc. has paid the full sum of $73.8 million owed to PDL from 2Q10

Read the full 219 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE